Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

The complexity of care for patients with rheumatoid arthritis: metrics for better understanding chronic disease care.

Kahn KL, MacLean CH, Liu H, Rubenstein LZ, Wong AL, Harker JO, Chen WP, Fitzpatrick DM, Bulpitt KJ, Traina SB, Mittman BS, Hahn BH, Paulus HE.

Med Care. 2007 Jan;45(1):55-65.

PMID:
17279021
2.

Application of explicit process of care measurement to rheumatoid arthritis: Moving from evidence to practice.

Kahn KL, MacLean CH, Liu H, Rubenstein LZ, Wong AL, Harker JO, Chen WP, Fitzpatrick DM, Bulpitt KJ, Traina SB, Mittman BS, Hahn BH, Paulus HE.

Arthritis Rheum. 2006 Dec 15;55(6):884-91.

3.

Dating the "window of therapeutic opportunity" in early rheumatoid arthritis: accuracy of patient recall of arthritis symptom onset.

Amjadi S, Khanna D, Park GS, Bulpitt KJ, Wong WK, Paulus HE.

J Rheumatol. 2004 Sep;31(9):1686-92. Erratum in: J Rheumatol. 2011 Jan;38(1):183. Amjadi-Begvand, Sogol [corrected to Amjadi, Sogol].

PMID:
15338485
4.

Development and evaluation of a patient self-report case-finding method for rheumatoid arthritis.

Wong AL, Harker JO, Mittman BS, Levy GD, Bulpitt KJ, Colburn KK, Liu H, Kahn KL, Hahn BH, Paulus HE, Rubenstein LZ.

Semin Arthritis Rheum. 2004 Aug;34(1):484-99.

PMID:
15305246
5.

Case finding for population-based studies of rheumatoid arthritis: comparison of patient self-reported ACR criteria-based algorithms to physician-implicit review for diagnosis of rheumatoid arthritis.

Liu H, Harker JO, Wong AL, Maclean CH, Bulpitt KJ, Mittman BS, Fitzgerald J, Grossman J, Rubenstein LZ, Hahn B, Paulus HE, Kahn KL.

Semin Arthritis Rheum. 2004 Apr;33(5):302-10.

PMID:
15079761
6.

Classifying structural joint damage in rheumatoid arthritis as progressive or nonprogressive using a composite definition of joint radiographic change: a preliminary proposal.

Paulus HE, Oh M, Sharp JT, Gold RH, Wong WK, Park GS, Bulpitt KJ; Western Consortium of Practicing Rheumatologists.

Arthritis Rheum. 2004 Apr;50(4):1083-96.

7.

Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein, Ro 45-2081 (lenercept): results of a dose-finding study in rheumatoid arthritis.

Furst DE, Weisman M, Paulus HE, Bulpitt K, Weinblatt M, Polisson R, Zaug M, Kneer J, Van der Auwera P, Stevens RM.

J Rheumatol. 2003 Oct;30(10):2123-6.

PMID:
14528504
8.

Etanercept added to background methotrexate therapy in patients with rheumatoid arthritis: continued observations.

Kremer JM, Weinblatt ME, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Jackson CG, Atkins KM, Feng A, Burge DJ.

Arthritis Rheum. 2003 Jun;48(6):1493-9.

9.

Correlation of single time-point damage scores with observed progression of radiographic damage during the first 6 years of rheumatoid arthritis.

Paulus HE, Oh M, Sharp JT, Gold RH, Wong WK, Park GS, Bulpitt KJ; Western Consortium of Praticing Rheumatologists.

J Rheumatol. 2003 Apr;30(4):705-13.

PMID:
12672187
10.

Allele and antigen-specific treatment of rheumatoid arthritis: a double blind, placebo controlled phase 1 trial.

Kavanaugh A, Genovese M, Baughman J, Kivitz A, Bulpitt K, Olsen N, Weisman M, Matteson E, Furst D, van Vollenhoven R, Anderson J, Cohen S, Wei N, Meijerink J, Jacobs C, Mocci S.

J Rheumatol. 2003 Mar;30(3):449-54.

PMID:
12610799
11.

Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment.

Paulus HE, Wiesner J, Bulpitt KJ, Patnaik M, Law J, Park GS, Wong WK.

J Rheumatol. 2002 Dec;29(12):2513-20.

PMID:
12465144
12.

Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis.

Moreland LW, Cohen SB, Baumgartner SW, Tindall EA, Bulpitt K, Martin R, Weinblatt M, Taborn J, Weaver A, Burge DJ, Schiff MH.

J Rheumatol. 2001 Jun;28(6):1238-44.

PMID:
11409115
13.
14.

Relative contributions of the components of the American College of Rheumatology 20% criteria for improvement to responder status in patients with early seropositive rheumatoid arthritis.

Paulus HE, Bulpitt KJ, Ramos B, Park G, Wong WK; Western Consortium of Practicing Rheumatologists.

Arthritis Rheum. 2000 Dec;43(12):2743-50.

15.

Biologic therapies in rheumatoid arthritis.

Bulpitt KJ.

Curr Rheumatol Rep. 1999 Dec;1(2):157-63. Review.

PMID:
11123030
16.

Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.

Newhall-Perry K, Law NJ, Ramos B, Sterz M, Wong WK, Bulpitt KJ, Park G, Lee M, Clements P, Paulus HE.

J Rheumatol. 2000 May;27(5):1156-63.

PMID:
10813281
17.

Patient self-report tender and swollen joint counts in early rheumatoid arthritis. Western Consortium of Practicing Rheumatologists.

Wong AL, Wong WK, Harker J, Sterz M, Bulpitt K, Park G, Ramos B, Clements P, Paulus H.

J Rheumatol. 1999 Dec;26(12):2551-61.

PMID:
10606362
19.

Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD.

Williams HJ, Alarcon GS, Joks R, Steen VD, Bulpitt K, Clegg DO, Ziminski CM, Luggen ME, St Clair EW, Willkens RF, Yarboro C, Morgan JG, Egger MJ, Ward JR.

J Rheumatol. 1999 Apr;26(4):816-25.

PMID:
10229402
20.

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

Moreland LW, Schiff MH, Baumgartner SW, Tindall EA, Fleischmann RM, Bulpitt KJ, Weaver AL, Keystone EC, Furst DE, Mease PJ, Ruderman EM, Horwitz DA, Arkfeld DG, Garrison L, Burge DJ, Blosch CM, Lange ML, McDonnell ND, Weinblatt ME.

Ann Intern Med. 1999 Mar 16;130(6):478-86.

PMID:
10075615
21.

A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate.

Weinblatt ME, Kremer JM, Bankhurst AD, Bulpitt KJ, Fleischmann RM, Fox RI, Jackson CG, Lange M, Burge DJ.

N Engl J Med. 1999 Jan 28;340(4):253-9.

22.

Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases.

Williams HJ, Alarcón GS, Neuner R, Steen VD, Bulpitt K, Clegg DO, Ziminski CM, Luggen ME, Polisson RP, Willkens RF, Yarboro C, Morgan J, Egger MJ, Ward JR.

J Rheumatol. 1998 Feb;25(2):261-8.

PMID:
9489817
23.

The relationship between socioeconomic status and recently diagnosed rheumatoid arthritis.

Berkanovic E, Oster P, Wong WK, Bulpitt K, Clements P, Sterz M, Paulus H.

Arthritis Care Res. 1996 Dec;9(6):257-62.

PMID:
9136289
24.

Monitoring radiographic changes in early rheumatoid arthritis.

Paulus HE, van der Heijde DM, Bulpitt KJ, Gold RH.

J Rheumatol. 1996 May;23(5):801-5. No abstract available.

PMID:
8724287
25.

CAMPATH-1H in rheumatoid arthritis--an intravenous dose-ranging study.

Isaacs JD, Manna VK, Rapson N, Bulpitt KJ, Hazleman BL, Matteson EL, St Clair EW, Schnitzer TJ, Johnston JM.

Br J Rheumatol. 1996 Mar;35(3):231-40.

PMID:
8620297
26.

CAMPATH-1H, a humanized monoclonal antibody, in refractory rheumatoid arthritis. An intravenous dose-escalation study.

Weinblatt ME, Maddison PJ, Bulpitt KJ, Hazleman BL, Urowitz MB, Sturrock RD, Coblyn JS, Maier AL, Spreen WR, Manna VK, et al.

Arthritis Rheum. 1995 Nov;38(11):1589-94.

PMID:
7488279
27.

Rheumatoid arthritis. Outcome measures.

Paulus HE, Bulpitt KJ.

Rheum Dis Clin North Am. 1995 Aug;21(3):605-18. Review.

PMID:
8619091
28.

DC-ART classification: review of relevant clinical studies.

Paulus HE, Bulpitt KJ.

J Rheumatol Suppl. 1994 Sep;41:8-20; discussion 20-2. Review.

PMID:
7799392
29.

Clinical trials of osteoarthritis therapies.

Paulus HE, Bulpitt KJ.

Br J Rheumatol. 1993 Jul;32(7):529-31. No abstract available.

PMID:
8339118
30.

Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis).

Bulpitt KJ, Clements PJ, Lachenbruch PA, Paulus HE, Peter JB, Agopian MS, Singer JZ, Steen VD, Clegg DO, Ziminski CM, Alarcon GS, Luggen ME, Polisson RP, Willkens RF, Reading JC, Williams HJ, Ward JR.

Ann Intern Med. 1993 Apr 15;118(8):602-9.

PMID:
8452326
31.
33.

Anaphylaxis to infusion of autologous bone marrow: an apparent reaction to self, mediated by IgE antibody to bovine serum albumin.

Macy E, Bulpitt K, Champlin RE, Saxon A.

J Allergy Clin Immunol. 1989 May;83(5):871-5.

PMID:
2654255
34.
36.
37.

Supplemental Content

Loading ...
Support Center